Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation
Autonomix Medical received Canadian Patent No. 3,183,802 covering its catheter-based transvascular technologies for accessing, guiding, and validating therapy delivery beyond the vessel wall. The company's global IP portfolio now includes 112 issued or pending patent applications, with corresponding patents already issued in the United States and Europe and expirations extending into the late 2030s.
Key figures
- Patent expiration
- late 2030s
- Canadian patent number
- 3,183,802
- Issued or pending patents
- 112
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.